跳至主要内容
临床试验/IRCT20081019001369N7
IRCT20081019001369N7尚未招募2 期

Evaluation of trans sodium crocetinate spray against on mild to moderate ARDS induced by COVID-19 patients: A Randomized Open label Clinical Trial

Mashhad University of Medical Sciences0 个研究点目标入组 30 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 75 years(—)
性别
All

入选标准

  • Patients with clinical diagnosis for COVID-19 disease
  • Patients with acute respiratory distress syndrome (ARDS)
  • PF ratio (the ratio of arterial oxygen partial pressure to fractional inspired oxygen) <200
  • Patients not having kidney, liver and heart dysfunction according to clinical and laboratory findings

排除标准

  • Allergic reactions to saffron
  • Pregnancy and breast-feeding,
  • Multi organ dysfunction disease

研究者

相似试验